You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 5, 2024

List of Excipients in API prochlorperazine


✉ Email this page to a colleague

« Back to Dashboard


Excipients in ANDA-approved (generic) drugs containing prochlorperazine

Company Ingredient NDC Excipient
Padagis US LLC prochlorperazine 0574-7226 GLYCERIN
Padagis US LLC prochlorperazine 0574-7226 GLYCERYL MONOSTEARATE
Padagis US LLC prochlorperazine 0574-7226 GLYCERYL PALMITATE
Padagis US LLC prochlorperazine 0574-7226 HYDROGENATED COCONUT OIL
Padagis US LLC prochlorperazine 0574-7226 HYDROGENATED PALM KERNEL OIL
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Sign Up

Detailed excipient profiles for prochlorperazine

Excipient focus: ALUMINUM OXIDE

Excipient focus: BENZYL ALCOHOL

prochlorperazine drug variants containing BENZYL ALCOHOL

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc prochlorperazine edisylate 0641-6135
Cosette Pharmaceuticals Inc prochlorperazine edisylate 0713-0351
Nexus Pharmaceuticals Inc prochlorperazine edisylate 14789-700
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-294
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-497
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: D&C YELLOW NO. 10

Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE

Excipient focus: DIETHYL PHTHALATE

Excipient focus: ETHYLCELLULOSE

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE YELLOW

Excipient focus: GLYCERIN

Excipient focus: GLYCERYL MONOSTEARATE

Excipient focus: GLYCERYL PALMITATE

Excipient focus: HYDROGENATED COCONUT OIL

Excipient focus: HYDROGENATED PALM KERNEL OIL

Excipient focus: HYPROMELLOSE

Excipient focus: HYPROMELLOSE 2910

Excipient focus: HYPROMELLOSES

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: PALM KERNEL OIL

Excipient focus: PALMITOSTEARIC ACID

Excipient focus: POLOXAMER 188

Excipient focus: POLYDEXTROSE

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 400

Excipient focus: POLYETHYLENE GLYCOL 6000

Excipient focus: POLYETHYLENE GLYCOL 8000

Excipient focus: POLYETHYLENE GLYCOLS

Excipient focus: POLYSORBATE 80

Excipient focus: SACCHARIN SODIUM

prochlorperazine drug variants containing SACCHARIN SODIUM

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc prochlorperazine edisylate 0641-6135
Hikma Pharmaceuticals USA Inc prochlorperazine edisylate 0641-6225
Cosette Pharmaceuticals Inc prochlorperazine edisylate 0713-0351
Nexus Pharmaceuticals Inc prochlorperazine edisylate 14789-700
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-294
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM PHOSPHATE, MONOBASIC

prochlorperazine drug variants containing SODIUM PHOSPHATE, MONOBASIC

Company Ingredient NDC
Nexus Pharmaceuticals Inc prochlorperazine edisylate 14789-700
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-294
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-497
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-523
A-S Medication Solutions prochlorperazine edisylate 50090-4548
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM PHOSPHATE, MONOBASIC ANHYDROUS

Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

prochlorperazine drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc prochlorperazine edisylate 0641-6135
Hikma Pharmaceuticals USA Inc prochlorperazine edisylate 0641-6225
Cosette Pharmaceuticals Inc prochlorperazine edisylate 0713-0351
Sagent Pharmaceuticals prochlorperazine edisylate 25021-790
Baxter Healthcare Corporation prochlorperazine edisylate 43066-090
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM TARTRATE

prochlorperazine drug variants containing SODIUM TARTRATE

Company Ingredient NDC
Nexus Pharmaceuticals Inc prochlorperazine edisylate 14789-700
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-294
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-497
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-523
A-S Medication Solutions prochlorperazine edisylate 50090-4548
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Excipient focus: SODIUM TARTRATE DIHYDRATE

Excipient focus: STARCH, CORN

Excipient focus: STEARIC ACID

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: TRIACETIN

Excipient focus: WATER

prochlorperazine drug variants containing WATER

Company Ingredient NDC
Hikma Pharmaceuticals USA Inc prochlorperazine edisylate 0641-6135
Hikma Pharmaceuticals USA Inc prochlorperazine edisylate 0641-6225
Cosette Pharmaceuticals Inc prochlorperazine edisylate 0713-0351
Nexus Pharmaceuticals Inc prochlorperazine edisylate 14789-700
Heritage Pharmaceuticals Inc d/b/a Avet Pharmaceuticals Inc prochlorperazine edisylate 23155-294
>Company >Ingredient >NDC

Subscribe to access the full database, or Sign Up

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
 NCE-1 Patent Challenge Dates 2024 - 2025
 Trigger-based marketing for the life sciences
 Get DrugPatentWatch Business Intelligence Reports at Amazon.com
 DrugChatter - AI-based answers to questions about drugs
 RxJam - Digital Marketing for Life Sciences
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links

Follow DrugPatentWatch:

  DrugPatentWatch Linkedin Group